Phase 4 N=46 Evaluation of Dexmedetomidine on Post-operative Narcotic Requirements and Pain Scores in Bariatric Patients
Pain
Primary: Quantity of Narcotic Utilized by Patient for Pain in Milligrams at 240 Minutes — 2.66; 3.7 mg
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=86 Pregabalin for the Treatment of Pain After Posterior Spinal Fusions
Lumbar Spinal Fusions
Primary: Patient Controlled Analgesia (PCA) Hydromorphone Usage — 44; 39 mL
Phase 3 N=74 Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery
Non-obstructive Azoospermia
Primary: Pain Score as Measured by the NRS-11 Scale — 1.91; 3.05; 2.27; 3.24 scores on a scale — p=0.01
Phase 2 N=10 Repeated Cannabis Administration on Experimental Pain and Abuse Liability
Cannabis · Pain · Tolerance
Primary: Change in Cold Pressor Test (CPT) Latency — 21.40; 10.94; 2.07; 15.17 percent change from Day 1 baseline
N/A N=75 Family Based Contingency Management for Adolescent Alcohol Abuse
Alcohol Abuse
Primary: Alcohol Abstinence — 2.9; 2.6 Samples — p=0.66
Phase 4 N=100 RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Operative Vaginal Reconstruction Pain
Post Operative Pain
Primary: Pain While Active - 18 hr — 42.0; 50.0 mm — p=0.328
Phase 4 N=32 Narcotic Free TIVA and Incidence of Unacceptable Movements Under Anesthesia During ACDF Surgery
Anterior Cervical Discectomy and Fusion (ACDF)
Primary: Incidence of Unacceptable Movement Under General Anesthesia — 1; 1 Participants
Phase 4 N=85 Multimodal Analgesia With Acetaminophen vs. Narcotics Alone After Hip Arthroscopy
Hip Arthroscopy
Primary: Patient Satisfaction — 8.48; 8.83 score on a scale
Phase 3 N=48 Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery
Meniscus Tear, Tibial · Pain, Postoperative · Postoperative Complications
Primary: Pain Levels Recorded With a Visual Analogue Scale — 25.6; 28.8 score on a scale
Phase 4 N=8 Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse
Attention Deficit Hyperactivity Disorder
Primary: Number of Participants With at Least 70% Reduction in ADHD Symptoms as Measured by Change in ADHD Rating Scale From First to Last Visit — 6; 2 participants
N/A N=153 Treatment for Adolescent Marijuana Abuse
Marijuana Abuse
Primary: Marijuana Abstinence (2 Weeks or Greater) — 72.5; 68.6; 45.1 percentage of participants
Phase 2 N=48 Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment
Substance Abuse · Substance Dependence · Cognitive Impairment
Primary: Days of Sobriety in First 90 Days — 87.3; 84.64 Days of Sobriety — p=.55
N/A N=173 SET-Recovery/Healthy Home
Substance-Related Disorders · Mental Health
Primary: Trajectory of Depression of Participants — 40; 28; 18; 27 Participants — p=<.05
Phase 4 N=37 Comparing Pediatric Dental Oral Sedation Outcomes With and Without Meperidine in Children Aged 3-7 Years
Dental Caries in Children · Pediatric Dental Sedation · Meperidine
Primary: Number of Participants With Successful Sedation — 11; 9 Participants
Phase 4 N=137 Safety Study of Analgesia After Craniotomy Surgery With End Tidal (ET) Carbon Dioxide (CO2) Monitoring
Pain
Primary: Respiratory Depression — 10.9; 10.5 breaths/minute